Imatinib Impedes EMT and Notch signaling by Inhibiting p300 Acetyltransferase in Breast Cancer Cells

0
18
Scientists highlighted the ability of Imatinib to suppress epithelial-mesenchymal transition through modulation of the Notch signaling pathway, offering a novel therapeutic avenue for breast cancer treatment.
[Molecular Carcinogenesis]
Abstract